Pioneering platform to generate novel therapies with potential to treat a wide range of diseases Financing led by Science Creates Ventures and Meltwind to fund development of the platform and initial product candidates BRISTOL, UK, 23 May 2023 – Scarlet Therapeutics (“Scarlet”), a leader in red blood cell-based therapeutics, announces today that it has raised […]